The most-searched triple peptide research stack right now. Three compounds, three distinct repair mechanisms, one order. ≥98% purity on all three. COA included. Shipping worldwide.
The glow blend peptide is a triple-compound research stack built around BPC-157, TB-500, and GHK-Cu. Each of the three components targets a completely different biological mechanism — which is exactly what makes the combination so interesting from a research standpoint.
BPC-157 drives local angiogenesis. TB-500 handles systemic cell migration. GHK-Cu activates collagen and extracellular matrix synthesis via copper-dependent pathways. Put them together and you have a model that covers all three phases of tissue repair in a single protocol — vascularization, cellular recruitment, and matrix reconstruction.
The "glow" name comes from GHK-Cu's well-documented role in skin collagen research — specifically its ability to upregulate collagen I, elastin, and glycosaminoglycans in treated tissue models. When paired with the repair and regeneration effects of BPC-157 and TB-500, researchers have access to one of the most comprehensive multi-pathway models currently available.
At VantyxLabs, all three compounds are available individually or as a coordinated glow blend order. Every batch is independently verified to ≥98% purity by HPLC, with a third-party Certificate of Analysis included as standard.
Body Protection Compound — 15 amino acid pentadecapeptide. Angiogenesis via VEGFR2/Akt/eNOS. Local tissue repair, NO signaling, gut mucosa, tendons, ligaments. 100+ preclinical studies indexed on PubMed.
Synthetic Thymosin Beta-4 fragment. G-actin sequestration, fibroblast and keratinocyte migration, systemic recovery. Works body-wide where BPC-157 acts locally — highly complementary.
Glycyl-L-histidyl-L-lysine copper complex. Collagen I & III synthesis, elastin, glycosaminoglycans. Antioxidant, anti-inflammatory, extracellular matrix regulation. The core "glow" compound.
All three compounds are shipped lyophilized with individual batch COA documentation. VantyxLabs does not ship below the ≥98% purity threshold — every order is traceable to its test batch.
| Compound | Purity | Molecular Weight | Key Research Area |
|---|---|---|---|
| BPC-157 | ≥98% | ~1,419 Da | Angiogenesis, tendon/ligament repair, gut health |
| TB-500 | ≥98% | ~4,964 Da | Cell migration, systemic recovery, muscle repair |
| GHK-Cu | ≥98% | ~340 Da | Collagen synthesis, skin matrix, antioxidant activity |
The reason this stack gets so much attention in research communities isn't hype — it's mechanism logic. The three compounds don't step on each other. They cover three distinct phases of the repair cascade, which means studying all three together gives you data that no single compound or two-compound combination can produce.
BPC-157 is a synthetic pentadecapeptide derived from human gastric juice protein. In preclinical models its primary documented mechanism is angiogenesis — triggering new blood vessel formation via the VEGFR2/Akt/eNOS signaling axis. This is the foundation of local tissue repair: without adequate vasculature, no meaningful healing can occur. Beyond angiogenesis, BPC-157 modulates nitric oxide production and growth factor signaling, with documented activity across tendon, ligament, gut mucosa, bone, and neural tissue in animal studies. The body of published research on BPC-157 is substantial — over 100 indexed studies are available via PubMed (NIH).
TB-500 is the synthetic counterpart to naturally-occurring Thymosin Beta-4, a protein that regulates the availability of G-actin — the unpolymerized pool of actin that drives cell motility. When TB-500 sequesters G-actin, fibroblasts, keratinocytes, and endothelial cells become more mobile and migrate toward sites of damage. This is a systemic effect — TB-500 doesn't just work at one location, it mobilizes repair cells throughout the body. That makes it an ideal complement to BPC-157, which creates the local vascular infrastructure those cells need to do their job. Research on Thymosin Beta-4 and its synthetic analogs is indexed extensively on PubMed.
GHK-Cu is a naturally occurring copper-binding tripeptide found in human plasma, saliva, and urine at concentrations that decline significantly with age. Its core mechanism is copper ion delivery to tissue — activating genes responsible for collagen I, collagen III, elastin, and glycosaminoglycan production. In skin tissue models specifically, GHK-Cu has been documented to stimulate collagen production, improve matrix organization, and reduce oxidative damage. It also demonstrates anti-inflammatory properties through copper-mediated redox regulation. This is what gives the glow blend its name — GHK-Cu's collagen and skin-matrix effects are the "glow" component of the stack, sitting on top of the repair foundation built by BPC-157 and TB-500.
Phase 1: BPC-157 builds the blood vessel network at the repair site. Phase 2: TB-500 mobilizes fibroblasts and endothelial cells and sends them there systemically. Phase 3: GHK-Cu provides the collagen and matrix scaffolding those cells need to reconstruct tissue properly. Each compound handles one phase. None of them overlap. No single compound or two-compound combination covers all three — which is exactly why the glow blend peptide has become the reference triple-stack in regenerative peptide research.
GHK-Cu is the primary driver here. Copper peptide studies have documented upregulation of collagen I and III, elastin, and glycosaminoglycans in treated dermal cell models. Adding BPC-157's angiogenic support (improved vascular delivery to skin tissue) and TB-500's fibroblast migration activity creates a multi-mechanism skin repair environment that outperforms GHK-Cu in isolation.
Research groups studying skin aging, wound closure rates, and dermal matrix disorders use the glow blend stack as a comprehensive coordinated model — because testing each compound separately misses the interaction effects.
BPC-157 and TB-500 are the gold-standard dual combination in preclinical recovery research. Each has independent peer-reviewed literature on tendon repair, muscle healing, ligament regeneration, and anti-inflammatory modulation. Together they're what researchers call the Wolverine Stack.
In the glow blend, GHK-Cu extends this further — adding connective tissue integrity and extracellular matrix strength research on top of the repair base. The result is a three-compound model covering tissue repair from vascular foundation all the way through to structural matrix reconstruction.
All three glow blend compounds have independent wound healing research profiles. BPC-157 accelerates wound closure in animal models via angiogenesis. TB-500 promotes keratinocyte migration — the primary cell type responsible for re-epithelialization. GHK-Cu improves collagen organization in healing tissue. Studying all three in a combined wound model gives researchers data on coordinated multi-pathway wound repair that no single compound can provide.
Each glow blend component contributes distinct anti-inflammatory activity. BPC-157 modulates COX-2 and inflammatory cytokines. TB-500 downregulates pro-inflammatory mediators through Thymosin Beta-4 pathways. GHK-Cu acts as an antioxidant via copper-mediated redox regulation and has been shown to reduce TNF-alpha levels in cell culture models. The combined anti-inflammatory profile makes the glow blend stack a strong model for multi-pathway inflammation research.
VantyxLabs ships to researchers across Europe, Asia, Southeast Asia, the Middle East, and beyond. Most vendors carrying this stack are based in the US and don't serve international orders reliably. Here's who we typically supply:
If you need bulk quantities or custom packaging for institutional research, contact us directly on WhatsApp — we handle larger orders regularly.
Every batch of BPC-157, TB-500, and GHK-Cu leaves our warehouse with a third-party Certificate of Analysis that confirms: HPLC purity ≥98%, mass spectrometry molecular identity verification, endotoxin levels via LAL assay, and physical appearance. Batch numbers are traceable — if you ever need to cross-reference your COA, we have it on file.
The easiest way to order is via WhatsApp — message us directly with what you need and we'll confirm stock, pricing, and shipping timeline for your country on the same day. We accept international research orders and ship discreetly with appropriate research-grade labeling and full tracking.
You can order all three compounds as a glow blend bundle or purchase any component individually if you already have one of the three in stock.
Here's a quick breakdown of where the glow blend fits versus related stacks and single compounds:
| Stack | Compounds | Research Focus | Best For |
|---|---|---|---|
| Glow Blend | BPC-157 + TB-500 + GHK-Cu | Repair + collagen + skin matrix | Multi-system regeneration research |
| Wolverine Stack | BPC-157 + TB-500 | Tissue repair + systemic recovery | Tendon, muscle, ligament models |
| BPC-157 alone | BPC-157 | Local angiogenesis, gut repair | Single injury site studies |
| GHK-Cu alone | GHK-Cu | Collagen, skin aging | Dermatology / skin matrix research |
BPC-157 + TB-500 + GHK-Cu. ≥98% purity on all three. COA included. Shipping worldwide from VantyxLabs.
Research use only. Not for human consumption. See full disclaimer.